Lambent Data has been selected to join the second cohort of the jointly created MassChallenge - IBM mentorship program for underrepresented founders.
The program, which aims to provide AI mentoring support and resources to high-impact startups with historically underrepresented founders, was expanded this year to include start-ups innovating with cyber and data security, as well as artificial intelligence elements.
The facilitators of the program will be drawn from experts within IBM’s artificial intelligence, data security, and other sectors, as well as members of the MassChallenge community (dedicated to working with early stage entrepreneurs). Through one-on-one mentoring and bi-weekly “Lunch and Learns,” entrepreneurs will engage with the experts and one another. This will progress the program’s aims which are to provide equitable access for underrepresented founders across all industries and to cultivate an inclusive innovation environment for all, in technical, strategic, and operational areas. The program kicked off on May 11 and extends through mid-July.
Lambent had previously been chosen for the 2021 MassChallenge Early Stage Accelerator (July - October 2021); Lambent’s participation had helped the company strongly progress, and we are greatly looking forward to this 2022 MassChallenge - IBM program also.
Lambent Data is an early stage social impact company which has developed the OurREACH™ bi-directional software platform and app, with data analytics. This HIPAA-compliant platform, which is very flexible in nature, lays a robust and collaborative framework for healthcare and social service providers to help families achieve better outcomes in health and Social Determinants of Health (housing, jobs, education, and more). It also includes many parenting resources. Because it’s so granular for patients and clients, it generates new data analytics never before available to providers, which they can use to improve their programs. The improved patient/client outcomes also lead to lower healthcare costs, which are crucial in preventive and value-based care.
